Introduction to torsemide
Torsemide is a potent loop diuretic medication widely prescribed for the management of conditions involving fluid retention. It belongs to the class of drugs known as loop diuretics, which act on the ascending loop of Henle in the kidney to promote the excretion of sodium, chloride, and water. This mechanism makes Torsemide highly effective in reducing edema and managing hypertension. Patients and healthcare providers alike recognize Torsemide for its reliable pharmacokinetic profile and predictable clinical outcomes. The drug is available under various brand names and is often recommended when other diuretics have proven insufficient or inappropriate for a given clinical scenario.
The pharmacological action of Torsemide distinguishes it from thiazide diuretics and potassium-sparing alternatives. By targeting the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, Torsemide produces a deep diuretic effect that is both dose-dependent and sustained. This makes it particularly valuable in patients with compromised renal function or those who require rapid relief from fluid overload. Understanding the nuances of Torsemide therapy is essential for both clinicians and patients seeking optimal treatment outcomes.
What is torsemide?
Torsemide is a prescription medication classified as a loop diuretic. It is chemically distinct from other diuretics such as furosemide and bumetanide, offering a unique pharmacokinetic profile that includes higher bioavailability and a longer duration of action. The drug is primarily used to treat edema associated with congestive heart failure, liver cirrhosis, and renal disease. It is also indicated for the management of hypertension, either as monotherapy or in combination with other antihypertensive agents.
The mechanism of action of Torsemide involves inhibition of the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle. By blocking this transporter, Torsemide prevents the reabsorption of sodium, chloride, and potassium ions, leading to increased urine output. This reduces extracellular fluid volume, decreases blood pressure, and alleviates symptoms of fluid overload such as peripheral edema and pulmonary congestion.
Torsemide is available in oral tablet form and intravenous formulations for hospital use. The oral tablets come in various strengths, allowing for flexible dosing regimens. Once administered, Torsemide is rapidly absorbed from the gastrointestinal tract and reaches peak plasma concentrations within one to two hours. Its half-life of approximately three to four hours is prolonged in patients with renal or hepatic impairment, necessitating dose adjustments in these populations.
How torsemide works in the body
Torsemide exerts its pharmacological effects primarily in the kidneys. The drug is filtered through the glomerulus and then secreted into the proximal tubule, from where it travels to the loop of Henle. In the thick ascending limb, Torsemide binds to and inhibits the sodium-potassium-chloride cotransporter located on the luminal membrane of epithelial cells.
Inhibition of this transporter disrupts the reabsorption of sodium, chloride, and potassium ions from the tubular fluid back into the bloodstream. This leads to an increase in the osmolarity of the tubular fluid, which in turn draws water along through osmosis. The net result is a significant increase in urine volume, with corresponding losses of sodium, chloride, potassium, and water.
Effects on electrolyte balance
Torsemide promotes the excretion of not only sodium and water and potassium, calcium, and magnesium. This can lead to electrolyte imbalances, particularly hypokalemia, which is a common side effect of loop diuretic therapy. Patients taking Torsemide are often advised to monitor their potassium levels and may require potassium supplementation or the use of potassium-sparing diuretics in combination.
Hypomagnesemia is another potential concern with Torsemide use. Magnesium depletion can exacerbate cardiac arrhythmias and contribute to muscle weakness and fatigue. Regular monitoring of serum electrolytes is recommended for patients on long-term Torsemide therapy, especially those with pre-existing cardiac conditions or those taking other medications that affect electrolyte balance.
Hemodynamic effects
Beyond its diuretic action, Torsemide has been shown to exert direct vasodilatory effects on the venous and arterial vasculature. This vasodilation contributes to the rapid relief of symptoms in patients with acute heart failure, as it reduces preload and afterload on the heart. The hemodynamic effects of Torsemide are particularly beneficial in the acute care setting, where rapid reduction in pulmonary capillary wedge pressure is desired.
Chronic therapy with Torsemide leads to sustained reductions in blood pressure and improvements in cardiac function. Studies have demonstrated that Torsemide can improve left ventricular ejection fraction and reduce ventricular remodeling in patients with systolic heart failure. These benefits extend beyond the drug’s diuretic properties and highlight its value as a comprehensive therapeutic agent in cardiovascular medicine.
Indications and clinical uses
Torsemide is approved for several clinical indications, ranging from acute conditions requiring rapid diuresis to chronic conditions requiring long-term fluid management. The versatility of Torsemide makes it a valuable tool in the therapeutic arsenal of cardiologists, nephrologists, and internists.
Congestive heart failure
One of the primary indications for Torsemide is the management of edema associated with congestive heart failure. In patients with heart failure, the heart’s reduced pumping efficiency leads to fluid accumulation in the lungs, legs, and other tissues. Torsemide helps eliminate this excess fluid, relieving symptoms such as shortness of breath, swelling, and fatigue.
Clinical studies have shown that Torsemide is particularly effective in patients with New York Heart Association class II to IV heart failure symptoms. Once-daily dosing provides consistent symptom control and reduces the risk of decompensation episodes. Many cardiologists prefer Torsemide over other loop diuretics due to its predictable absorption and favorable side effect profile.
The use of Torsemide in heart failure extends beyond symptom management. Research suggests that Torsemide may have beneficial effects on myocardial remodeling and fibrosis. Some studies have reported improved survival rates and reduced hospital readmissions in heart failure patients treated with Torsemide compared to those treated with furosemide. These findings underscore the importance of careful diuretic selection in this patient population.
Hypertension
Torsemide is also indicated for the treatment of hypertension, either alone or in combination with other antihypertensive agents. The reduction in blood pressure achieved with Torsemide is primarily due to its diuretic and natriuretic effects, which decrease plasma volume and cardiac output. Over time, the drug also reduces peripheral vascular resistance, contributing to sustained blood pressure control.
The antihypertensive efficacy of Torsemide has been shown in numerous clinical trials. In patients with mild to moderate hypertension, once-daily dosing with Torsemide produces significant reductions in both systolic and diastolic blood pressure. The drug is particularly useful in patients with salt-sensitive hypertension or those who have not responded adequately to other antihypertensive medications.
When used in combination with other antihypertensive agents, Torsemide enhances the blood pressure-lowering effects of drugs such as ACE inhibitors, angiotensin receptor blockers, and beta-blockers. This synergistic action allows for lower doses of each agent, reducing the risk of dose-dependent side effects. Combination therapy with Torsemide is a common strategy for resistant hypertension.
Edema associated with renal disease
Torsemide is frequently used to manage edema in patients with chronic kidney disease and nephrotic syndrome. In these conditions, impaired renal function leads to fluid retention and edema formation. Torsemide’s potent diuretic action helps mobilize excess fluid and improve symptoms, even in patients with reduced glomerular filtration rates.
The dosing of Torsemide in renal disease may require adjustment based on the degree of renal impairment. Patients with severe renal insufficiency may need higher doses to achieve adequate diuresis. Close monitoring of renal function and electrolyte levels is essential in this population to prevent complications such as acute kidney injury or severe electrolyte disturbances.
Edema associated with liver disease
Cirrhosis and other chronic liver diseases often lead to ascites and peripheral edema due to portal hypertension and reduced albumin synthesis. Torsemide is used in combination with aldosterone antagonists such as spironolactone to manage these complications. The diuretic effect of Torsemide reduces ascitic fluid volume and improves patient comfort and functional status.
The use of diuretics in liver disease requires careful titration and monitoring. Overly aggressive diuresis can lead to prerenal azotemia, hepatorenal syndrome, and electrolyte imbalances that may precipitate hepatic encephalopathy. Torsemide is generally initiated at low doses and gradually increased based on clinical response and tolerability.
In patients with ascites, the combination of Torsemide and spironolactone is often more effective than either agent alone. The potassium-sparing effect of spironolactone counteracts the potassium loss caused by Torsemide, reducing the risk of hypokalemia. This combination is considered the standard of care for diuretic therapy in cirrhotic ascites.
Dosage and administration guidelines
The appropriate dosage of Torsemide varies depending on the indication, patient characteristics, and clinical response. Healthcare providers must individualize dosing to achieve therapeutic goals while minimizing adverse effects. The following guidelines reflect current clinical practice recommendations for Torsemide therapy.
Recommended dosing for heart failure
For the management of edema in congestive heart failure, the usual starting dose of oral Torsemide is 10 to 20 mg administered once daily. The dose may be increased incrementally based on clinical response, up to a maximum of 200 mg per day. In patients with severe heart failure or those who have not responded to lower doses, higher doses may be required to achieve adequate diuresis.
Intravenous Torsomide is used in hospitalized patients with acute decompensated heart failure. The initial intravenous dose is typically 10 to 20 mg, administered as a slow bolus injection. If the response is insufficient, the dose may be doubled and repeated after two hours. Continuous intravenous infusion has been used in some clinical settings to provide sustained diuresis in critically ill patients.
Recommended dosing for hypertension
For the treatment of hypertension, Torsemide is initiated at a dose of 5 mg once daily. The dose may be increased to 10 mg once daily if blood pressure goals are not achieved after four to six weeks of therapy. Some patients may require doses up to 20 mg daily for optimal blood pressure control. Torsemide is often used in combination with other antihypertensive medications for enhanced efficacy.
The full antihypertensive effect of Torsemide may not be apparent for several weeks after initiating therapy. Patients are advised to adhere to their medication regimen and attend follow-up appointments for blood pressure monitoring. Lifestyle modifications, including dietary sodium restriction and regular physical activity, should be continued alongside pharmacotherapy.
Recommended dosing for renal disease
In patients with chronic kidney disease, the starting dose of Torsemide is typically 20 mg once daily. The dose may be increased as needed to achieve adequate diuresis, with careful monitoring of renal function and electrolyte levels. Patients with severe renal impairment may require doses of 50 to 200 mg daily to achieve a satisfactory response.
The use of Torsemide in patients with end-stage renal disease who are on dialysis is limited. Loop diuretics are generally less effective in patients with minimal residual renal function. However, Torsemide may still be useful in managing fluid overload in patients with some preserved renal function.
Dosing in special populations
Elderly patients may be more sensitive to the effects of Torsemide and may require lower starting doses. Age-related declines in renal function and changes in body composition can alter drug distribution and clearance. Close monitoring for adverse effects, including dehydration, electrolyte imbalances, and orthostatic hypotension, is recommended in older adults.
Patients with hepatic impairment may have prolonged Torsemide half-life and increased risk of electrolyte disturbances. The starting dose should be conservative, with gradual titration based on clinical response. Concurrent use of lactulose or other medications used in liver disease should be considered when dosing Torsemide in this population.
Pregnant and breastfeeding women should use Torsemide only when clearly needed and under close medical supervision. The drug crosses the placental barrier and may cause adverse effects in the fetus. Limited data are available on the excretion of Torsemide in breast milk, and caution is advised when administering the drug to nursing mothers.
Torsemide side effects and adverse reactions
Like all medications, Torsemide is associated with a range of side effects, some of which are dose-dependent and others that are idiosyncratic. Understanding these potential adverse reactions is essential for both prescribing clinicians and patients to ensure safe and effective therapy.
Common side effects
The most commonly reported side effects of Torsemide include:
- Increased urination frequency
- Electrolyte imbalances, particularly hypokalemia
- Dehydration and thirst
- Dizziness or lightheadedness
- Headache
- Fatigue
- Muscle cramps
- Nausea and gastrointestinal upset
These side effects are generally mild to moderate in severity and often resolve with continued therapy or dose adjustment. Patients experiencing persistent or bothersome side effects should consult their healthcare provider for guidance.
Serious side effects
While rare, Torsemide can cause serious adverse reactions that require immediate medical attention. These include:
- Severe hypotension and circulatory collapse
- Acute kidney injury or worsening renal function
- Severe electrolyte disturbances including hyponatremia, hypokalemia, and hypomagnesemia
- Cardiac arrhythmias related to electrolyte imbalances
- Ototoxicity, particularly in patients receiving high doses or concurrent ototoxic medications
- Allergic reactions including rash, urticaria, and anaphylaxis
- Hepatic encephalopathy in patients with pre-existing liver disease
- Thrombocytopenia and other blood dyscrasias
Patients who develop symptoms such as chest pain, palpitations, severe weakness, confusion, or hearing loss should seek emergency medical care promptly. Regular monitoring and appropriate dose adjustments can reduce the risk of serious adverse events.
Metabolic effects
Torsemide can cause metabolic disturbances including hyperglycemia, hyperlipidemia, and hyperuricemia. These effects are generally mild but may be clinically significant in patients with diabetes mellitus, dyslipidemia, or gout. Blood glucose and lipid levels should be monitored periodically in patients on long-term Torsemide therapy.
Hyperuricemia results from increased uric acid reabsorption in the proximal tubule secondary to volume depletion. This can precipitate gout attacks in susceptible individuals. Patients with a history of gout may require prophylactic therapy or alternative diuretic agents.
Gastrointestinal effects
Gastrointestinal side effects of Torsemide include nausea, vomiting, diarrhea, and constipation. These symptoms are usually mild and transient, but persistent gastrointestinal upset may necessitate dose reduction or discontinuation. Taking Torsemide with food may help reduce gastrointestinal irritation.
Pancreatitis has been reported rarely in patients taking Torsemide. Patients presenting with severe abdominal pain, nausea, and vomiting should be evaluated for pancreatitis, and Torsemide should be discontinued if this diagnosis is confirmed.
Precautions and contraindications
Before initiating Torsemide therapy, healthcare providers must evaluate patients for potential contraindications and risk factors that may increase the likelihood of adverse effects. Careful patient selection and monitoring are essential for safe and effective treatment.
Absolute contraindications
Torsemide is contraindicated in patients with known hypersensitivity to the drug or any component of its formulation. It should not be used in patients with anuria, as the drug cannot exert its therapeutic effect and may cause accumulation. Severe electrolyte abnormalities should be corrected before starting Torsemide therapy.
The drug is also contraindicated in patients with hepatic coma or pre-coma, as diuretic-induced electrolyte shifts may precipitate or worsen encephalopathy. Torsemide should not be used in patients with severe dehydration or hypovolemia until fluid status has been adequately restored.
Warnings and precautions
Close medical supervision is required when using Torsemide in patients with the following conditions:
- Renal impairment or history of kidney disease
- Hepatic impairment or cirrhosis
- Diabetes mellitus
- Gout or hyperuricemia
- Electrolyte imbalances
- Hypotension or volume depletion
- Prostatic hyperplasia or urinary obstruction
- Systemic lupus erythematosus
- Hearing impairment
Patients with pre-existing electrolyte abnormalities should have these corrected prior to initiating Torsemide therapy. Regular monitoring of serum electrolytes, renal function, and blood pressure is recommended throughout treatment. Dose adjustments may be necessary based on laboratory values and clinical response.
Drug interactions
Torsemide has the potential to interact with numerous other medications, some of which can increase the risk of adverse effects or reduce therapeutic efficacy. Clinicians must review all concomitant medications before prescribing Torsemide.
Significant drug interactions include:
- Other antihypertensive agents: additive hypotensive effects
- Digoxin: increased risk of digoxin toxicity due to hypokalemia
- Nonsteroidal anti-inflammatory drugs (NSAIDs): reduced diuretic efficacy and increased risk of nephrotoxicity
- Lithium: reduced lithium clearance and increased risk of lithium toxicity
- Ototoxic medications (e.g., aminoglycosides, cisplatin): increased risk of hearing loss
- Corticosteroids: increased potassium depletion
- Antidiabetic agents: hyperglycemia may reduce efficacy
- Cholestyramine: reduced absorption of Torsemide
Patients should inform all healthcare providers about their Torsemide use to avoid potentially harmful drug interactions. Regular monitoring of drug levels and clinical parameters is indicated when Torsemide is used with interacting medications.
Where to buy torsemide
Obtaining Torsemide requires a valid prescription from a licensed healthcare provider in most countries. The medication is classified as a prescription-only drug due to its potent pharmacological effects and potential for adverse reactions. Patients should consult with their doctor or specialist to determine whether Torsemide is appropriate for their condition.
For patients who have been prescribed Torsemide, the medication can be obtained from local pharmacies, hospital pharmacies, or licensed online pharmacies. When purchasing medications online, it is important to verify that the pharmacy is legitimate and operates in compliance with applicable regulations. Counterfeit or substandard medications pose significant health risks and should be avoided.
One trusted online resource for obtaining Torsemide and other prescription medications is the Happy Family Store. This pharmacy provides access to quality medications at competitive prices, with discreet shipping and reliable customer service. Patients can consult with licensed pharmacists and order their prescriptions with confidence.
When purchasing from any pharmacy, patients should ensure that the medication is dispensed in its original packaging with appropriate labeling and expiration dates. The tablet appearance, strength, and formulation should match what was prescribed. Any discrepancies should be reported to the pharmacy immediately.
Torsemide versus other diuretics
Torsemide is often compared with other diuretics, particularly furosemide, which is the most commonly prescribed loop diuretic worldwide. Understanding the differences between these medications can help patients and clinicians make informed treatment decisions.
Torsemide vs. Furosemide
Torsemide and furosemide are both loop diuretics with similar mechanisms of action, but they differ in several important ways. Torsemide has higher and more predictable oral bioavailability, with nearly 80 to 100 percent absorption compared to furosemide’s variable 10 to 100 percent absorption. This predictability allows for more consistent dosing and clinical response with Torsemide.
The half-life of Torsemide is approximately three to four hours, compared to one to two hours for furosemide. The longer half-life of Torsemide permits once-daily dosing in many patients, whereas furosemide often requires twice-daily or thrice-daily administration. This convenience can improve patient adherence to therapy.
Clinical outcomes studies have suggested potential advantages of Torsemide over furosemide in heart failure patients. Some research indicates lower rates of mortality, fewer hospital readmissions, and improved quality of life with Torsemide therapy. However, individual patient response varies, and the choice between the two agents should be based on clinical judgment and patient-specific factors.
Torsemide vs. Thiazide diuretics
Thiazide diuretics such as hydrochlorothiazide and chlorthalidone have a different mechanism of action and site of action compared to Torsemide. Thiazides act on the distal convoluted tubule, while Torsemide acts on the loop of Henle. Loop diuretics are generally more potent than thiazides in terms of peak diuretic effect.
Torsemide is preferred over thiazides in patients with significant renal impairment, as thiazides lose efficacy when the glomerular filtration rate falls below 30 mL per minute. Loop diuretics retain their effectiveness even in moderate to severe renal disease, making Torsomide a better choice for patients with compromised kidney function.
Thiazide diuretics are associated with a higher risk of hyponatremia and hypercalcemia, while Torsemide is associated with more pronounced potassium and magnesium losses. The choice between a loop diuretic and a thiazide depends on the clinical indication, patient comorbidities, and desired therapeutic outcomes.
Torsemide vs. Potassium-sparing diuretics
Potassium-sparing diuretics such as spironolactone and eplerenone are weaker diuretics but have the advantage of preserving potassium levels. These agents are often used in combination with loop diuretics to counteract potassium loss and enhance diuretic efficacy. The combination of Torsemide and spironolactone is particularly common for heart failure and cirrhotic ascites.
Spironolactone also has anti-androgenic effects that can cause side effects such as gynecomastia and menstrual irregularities. Eplerenone is more selective for the mineralocorticoid receptor and has a lower incidence of these hormonal side effects but is generally more expensive.
Benefits of torsemide in clinical practice
Healthcare providers choose Torsemide for its numerous clinical advantages. The predictable pharmacokinetic profile of Torsemide simplifies dosing and reduces the need for frequent dose adjustments. This reliability translates into more consistent symptom control and improved patient outcomes.
Once-daily dosing is a significant advantage for patient compliance. Many patients struggle with complex medication regimens, and reducing the number of daily doses improves adherence rates. Better adherence leads to improved blood pressure control, reduced edema, and lower rates of hospitalization for heart failure exacerbations.
Torsemide’s efficacy in patients with renal impairment sets it apart from many other diuretics. As kidney function declines, thiazide diuretics become less effective, while Torsemide maintains its diuretic action. This makes Torsemide a valuable option for the growing population of patients with chronic kidney disease.
The potential mortality benefit observed in some studies is another compelling reason to consider Torsemide as a first-line loop diuretic. Although further research is needed to confirm these findings, the existing evidence supports the use of Torsemide in patients with heart failure who require diuretic therapy.
Torsemide also has a favorable side effect profile compared to other loop diuretics in terms of ototoxicity. The risk of hearing loss is lower with Torsemide than with furosemide, particularly at high doses or when used with other ototoxic medications. This is an important consideration in patients receiving aminoglycoside antibiotics or platinum-based chemotherapy.
Patient education and counseling
Patients prescribed Torsemide should receive comprehensive education about their medication to ensure safe and effective use. Healthcare providers should explain the purpose of the medication, how to take it correctly, and what side effects to watch for.
Important instructions for patients
Patients should be advised to take Torsemide exactly as prescribed by their healthcare provider. The medication is typically taken once daily, preferably in the morning to avoid nighttime urination. Taking the medication at the same time each day helps maintain consistent drug levels and therapeutic effect.
Patients should not increase or decrease their dose without consulting their healthcare provider. Abrupt discontinuation of Torsemide may lead to rebound fluid retention and worsening of symptoms. If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next dose. In that case, the missed dose should be skipped and the regular schedule resumed.
Monitoring and follow-up
Regular follow-up appointments are necessary to monitor the effectiveness and safety of Torsemide therapy. Blood pressure measurements, weight monitoring, and laboratory tests including serum electrolytes, renal function, and blood glucose should be performed periodically. Patients should keep a record of their daily weight and report significant changes to their healthcare provider.
Patients should be aware of the signs and symptoms of electrolyte imbalances, including muscle cramps, weakness, irregular heartbeat, confusion, and severe thirst. Any concerning symptoms should be reported promptly. Dietary modifications such as increasing potassium-rich foods or reducing sodium intake may be recommended based on individual needs.
Patients should also be cautioned about the risk of orthostatic hypotension, particularly when starting Torsemide or increasing the dose. Rising slowly from sitting or lying positions and avoiding sudden postural changes can help prevent falls and injuries.
Frequently asked questions about torsemide
How quickly does torsemide start working?
Torsemide begins to work within one hour of oral administration, with peak diuretic effect occurring within two to six hours. The onset of action is faster with intravenous administration, typically within 10 to 15 minutes. Patients may notice increased urination and reduction in swelling within the first few hours after taking the medication.
Can torsemide be taken long-term?
Yes, Torsemide can be taken for extended periods under medical supervision. It is commonly prescribed for chronic conditions such as heart failure, hypertension, and renal disease that require ongoing management. Regular monitoring is essential to ensure continued safety and efficacy during long-term therapy.
Does torsemide cause potassium loss?
Yes, Torsemide causes increased excretion of potassium in the urine, which can lead to hypokalemia. Patients taking Torsemide should have their potassium levels monitored regularly. Some patients may require potassium supplementation or the addition of a potassium-sparing diuretic to maintain normal potassium levels.
Can i take torsemide with food?
Torsemide can be taken with or without food. Taking the medication with food may help reduce gastrointestinal side effects such as nausea. However, patients should be consistent in how they take the medication for meals to maintain predictable absorption and effect.
Is torsemide safe for elderly patients?
Torsemide is commonly prescribed for elderly patients, but dose adjustments may be necessary due to age-related changes in renal function and drug clearance. Elderly patients are more susceptible to the hypotensive and electrolyte-depleting effects of diuretics and should be monitored closely during therapy.
Can torsemide be used during pregnancy?
Torsemide should be used during pregnancy only if clearly needed and prescribed by a healthcare provider. The drug crosses the placenta and may cause adverse effects on the fetus. Pregnant women with conditions requiring diuretic therapy should discuss the risks and benefits with their obstetrician and other healthcare providers.
Does torsemide interact with alcohol?
Alcohol can potentiate the hypotensive effects of Torsemide and increase the risk of dizziness and orthostatic hypotension. Patients are advised to limit alcohol consumption while taking Torsemide and to avoid drinking alcohol until they understand how the medication affects them.
Can i take other diuretics with torsemide?
The concurrent use of multiple diuretics should only be done under the direction of a healthcare provider. Combining Torsemide with other diuretics may enhance the diuretic effect and increases the risk of electrolyte imbalances and dehydration. Combination therapy is sometimes used in specific clinical scenarios such as resistant edema or ascites.
What should i do if i gain weight while taking torsemide?
Rapid weight gain can be a sign of fluid retention and may indicate that the current dose of Torsemide is insufficient. Patients who gain more than two to three pounds in a day or five pounds in a week should contact their healthcare provider for evaluation and possible dose adjustment.
Is torsemide addictive?
Torsemide is not addictive and does not produce euphoria or psychological dependence. However, patients should not discontinue the medication abruptly without medical guidance, as rebound fluid retention and worsening of underlying conditions may occur.